| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00395-009-0077-4 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s00395-009-0077-4 |
| P698 | PubMed publication ID | 20020305 |
| P5875 | ResearchGate publication ID | 40697597 |
| P50 | author | Glenn Marsboom | Q41942620 |
| Peter Pokreisz | Q44814520 | ||
| Frans Van de Werf | Q5492406 | ||
| P2093 | author name string | Pieter Vermeersch | |
| Zsolt Szelid | |||
| Erik Verbeken | |||
| Desire Collen | |||
| Hilde Gillijns | |||
| Xiaoshun Liu | |||
| Marijke Pellens | |||
| Stefan P Janssens | |||
| P2860 | cites work | Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo | Q43678586 |
| P433 | issue | 2 | |
| P921 | main subject | reperfusion injury | Q1413991 |
| P304 | page(s) | 169-179 | |
| P577 | publication date | 2009-12-18 | |
| P1433 | published in | Basic Research in Cardiology | Q2453360 |
| P1476 | title | Cardioselective nitric oxide synthase 3 gene transfer protects against myocardial reperfusion injury | |
| P478 | volume | 105 |
| Q37981008 | Cardiac gene therapy in large animals: bridge from bench to bedside. |
| Q36420890 | Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion |
| Q27311206 | Circulating NOS3 modulates left ventricular remodeling following reperfused myocardial infarction |
| Q35543543 | Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning |
| Q41884706 | Depletion of circulating blood NOS3 increases severity of myocardial infarction and left ventricular dysfunction |
| Q36481332 | Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation |
| Q36683881 | Endothelial NOS (NOS3) impairs myocardial function in developing sepsis |
| Q45941940 | Exercise-induced cardioprotection: a role for eNOS uncoupling and NO metabolites. |
| Q40258000 | Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences |
| Q34103142 | Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis |
| Q40257008 | Identification of inducible nitric oxide synthase in peripheral blood cells as a mediator of myocardial ischemia/reperfusion injury |
| Q34875396 | Impairment of endothelial-myocardial interaction increases the susceptibility of cardiomyocytes to ischemia/reperfusion injury |
| Q38272566 | Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis |
| Q49501122 | Nitric oxide signalling in cardiovascular health and disease. |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q36325484 | Protective effect of ginseng against gamma-irradiation-induced oxidative stress and endothelial dysfunction in rats |
| Q34092872 | eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex. |
| Q47701419 | l-arginine ingestion inhibits eccentric contraction-induced proteolysis and force deficit via S-nitrosylation of calpain. |
Search more.